Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Comparison Between Excision And Primary Anastomosis Urethroplasty And Tunica Vaginalis Graft Urethroplasty.

2 de agosto de 2026 actualizado por: Waqas Ali, Sahiwal medical college sahiwal

Comparison of Outcome Between Excision and Primary Anastomosis Urethroplasty and Tunica Vaginalis Graft Urethroplasty in Patients With Bulbar Urethral Stricture Upto 2cm in Length : A Randomized Controlled Trial

Urethroplasty is considered the gold standard for the treatment of urethral stricture disease, with a success rate of more than 93% in terms of stricture recurrence. The objective of this study is to compare the outcomes of excision and primary anastomosis (EPA) urethroplasty, a transecting urethroplasty technique, and tunica vaginalis graft (TVG) urethroplasty, a non-transecting urethroplasty technique, in patients with bulbar urethral strictures up to 2 cm in length.

This will be a randomized controlled trial (RCT) involving 94 patients admitted to Sahiwal Teaching Hospital, Sahiwal. The patients will be divided into two equal groups. Randomization will be performed using a computer-generated random sequence. Group A patients will undergo excision and primary anastomosis (EPA) urethroplasty, while Group B patients will undergo tunica vaginalis graft (TVG) urethroplasty. Non-probability convenience sampling will be used.

A detailed history of urinary symptoms, sexual function, catheterization, instrumentation, urinary tract infection, and trauma will be obtained to determine the cause of the stricture. Demographic information, including name, age, and contact number, will be recorded. Preoperative investigations will include complete blood count, renal function test, liver function test, urine complete examination, ultrasonography of the kidneys, ureters, and bladder with post-void residual volume (PVR), uroflowmetry, and retrograde urethrogram for the diagnosis and measurement of stricture length.

Other study parameters will include length of hospital stay and postoperative complications, such as graft failure, wound infection, urinary tract infection, and fistula formation. Data will be collected using a structured proforma and entered into the Statistical Package for the Social Sciences (SPSS) version 26.0 for analysis. For quantitative variables, the mean and standard deviation will be calculated. For qualitative variables, frequencies and percentages will be calculated. Data will be presented in tables and graphs for both quantitative and qualitative variables. The chi-square test will be used to assess the association between qualitative variables, while the independent samples t-test will be applied to quantitative variables. A p-value of less than 0.05 will be considered statistically significant.

It is anticipated that tunica vaginalis graft (TVG) urethroplasty will provide better outcomes than excision and primary anastomosis (EPA) urethroplasty.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

A proforma will be prepared by the researcher and finalized after pre-testing. The patients admitted to Sahiwal Teaching Hospital, Sahiwal will be assessed by the researcher, and the results will be recorded on the proforma. Patients will be admitted to the hospital one day before surgery.

A detailed history of urinary symptoms, sexual function, catheterization, instrumentation, urinary tract infection, and trauma will be obtained to determine the cause of the stricture. Demographic information, including name, age, and contact number, will be recorded. Preoperative investigations will include complete blood count, renal function test, liver function test, urine complete examination, ultrasonography of the kidneys, ureters, and bladder with post-void residual volume (PVR), uroflowmetry, and retrograde urethrogram for the diagnosis and measurement of stricture length.

A midline perineal incision will be made in the lithotomy position from the perineoscrotal junction to about 1 cm from the anal margin. The incision will be deepened through the subcutaneous tissue and Colles' fascia to expose the bulbospongiosus muscle. The bulbospongiosus muscle will be divided in the midline and retracted.

In Group A (excision and primary anastomosis urethroplasty) patients, an incision will be made down onto the catheter in the ventral midline. The urethra will be divided with scissors proximally and distally until healthy urethra is reached. Stay sutures will be placed. The scarred urethra will be excised, and the healthy proximal urethral segment will be spatulated dorsally so that it accommodates a 30 French bougie. The distal urethra will then be spatulated ventrally. The anastomosis will be performed using interrupted 4-0 polydioxanone (PDS) sutures.

In Group B (tunica vaginalis graft urethroplasty) patients, an incision will be made onto the urethra in the ventral midline along the length of the stricture, extending into the healthy proximal and distal urethra, and stay sutures will be positioned. The tunica vaginalis graft will be harvested by making a small vertical or transverse hemiscrotal incision. The dartos fascia will be divided to expose the tunica vaginalis. The testis will be gently delivered through the incision. The graft will be outlined on the parietal tunica vaginalis and carefully dissected while avoiding injury to the testis or epididymis. Hemostasis will be secured. The harvested tunica vaginalis graft will be placed on a sterile surface with the serosal surface facing upward and trimmed to the required size. The graft will be kept moist in normal saline until applied to the urethral site. The tunica vaginalis defect will be approximated, and the testis will be returned to the scrotum. The dartos fascia and skin will be closed in layers using absorbable sutures. The graft will be laid as a ventral onlay graft onto the opened urethral defect and sutured to the urethral mucosal edges using absorbable sutures. Quilting or anchoring sutures may be placed to reduce graft dead space and enhance graft take. The ventral urethrotomy will be closed over the catheter using absorbable sutures.

A 16 French soft silicone catheter will be kept in place for 2-3 weeks for urinary drainage. The bulbospongiosus muscle will be closed in the midline using interrupted 3-0 Vicryl sutures. A suction drain will be placed in the perineum overlying the muscle, and Colles' fascia will be closed using running 3-0 Vicryl sutures, followed by skin closure with running 4-0 chromic sutures. A clear adhesive dressing will be applied, and the patient will be placed in the supine position. The per-urethral Foley catheter will be removed 2-3 weeks after the procedure.

All procedures will be performed by experienced urologists using standardized surgical techniques to ensure consistency. Postoperative follow-up will be conducted at scheduled intervals as specified in the prescribed proforma. Data will be collected using the proforma.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

94

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Dr. Riaz ul Haq Professor, FCPS
  • Número de teléfono: 0092-40-4502470
  • Correo electrónico: slmcswl@gmail.com

Copia de seguridad de contactos de estudio

  • Nombre: Dr. Adeel Riaz Consultant, MD
  • Número de teléfono: 0092-40-4502470
  • Correo electrónico: slmcswl@gmail.com

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Patients with diagnosis of bulbar urethral stricture upto 2cm in length.
  • Patients aged between 18-50 years.
  • Patients with non-traumatic bulbar urethral stricture.
  • Isolated short (≤ 2 cm) bulbar urethral stricture
  • Patient is able and willing to comply with the postoperative protocol.

Exclusion Criteria:

  • Urethral stricture which is completely obliterated stricture.
  • Patients with history of hypospadias or previous open urethral surgery.
  • Patients with uncontrolled diabetes or Immunocompromised patients.
  • Patients unwilling for the follow-up.
  • History of pelvic radiation therapy
  • Patient with history of urethral instrumentation in last 3 months.
  • Lichen sclerosus related strictures.
  • Patients with history of erectile dysfunction, priapism or treatment to enhance erectile function.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Otro: Excision and Primary Anastomosis Urethroplasty
In Excision and Primary anastomosis urethroplasty patients, an incision will be made down onto the urethra at the level of stricture in the ventral midline. Urethra will be divided with scissors proximally and distally until healthy urethra is entered. Stay sutures will be placed. The scarred urethra will be excised, and the healthy proximal urethral segment will be spatulated dorsally so that it accommodates a 30Fr bougie and the distal urethra will then be spatulated ventrally. The anastomosis will be done using interrupted sutures of 4-0 polydioxanone (PDS).
Otro: Tunica Vaginalis Graft Urethroplasty
In Tunica Vaginalis Graft Urethroplasty patients, an incision will be made onto the urethra in the ventral mid-line along the stricture length, opening into healthy proximal and distal urethra and stay sutures will be positioned. Tunica vaginalis graft is harvested by making a small vertical or transverse hemiscrotal incision. The dartos fascia is divided to expose the tunica vaginalis. The testis is gently delivered through the incision.The tunica vaginalis graft outlined and harvested. The tunica vaginalis defect is approximated and testis is placed back into the scrotum. The dartos and skin are closed in layers using absorbable sutures. The graft will be laid as a ventral onlay graft onto the opened urethral defect and sutured to the urethral mucosal edges using absorbable sutures. Quilting or anchoring sutures may be placed to reduce graft dead space and enhance take. Ventral urethrotomy is closed over the catheter using absorbable sutures.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Stricture Recurrence
Periodo de tiempo: 12 months
Defined as the presence of a recurrent stricture on retrograde urethrogram (RUG) or the need for any secondary intervention (e.g., dilatation, direct visual internal urethrotomy, or repeat urethroplasty) within 12 months of the initial surgery.
12 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Maximum Urine Flow Rate (Qmax)
Periodo de tiempo: 12 months
The highest rate of urine flow in milliliters per second (mL/s) as measured by uroflowmetry. The primary analysis will compare the mean change in Qmax postoperatively.
12 months
Erectile Dysfunction
Periodo de tiempo: 12 months
Erectile dysfunction (ED) has been defined as the inability to attain or maintain penile erection sufficient for successful sexual intercourse. The severity of erectile dysfunction is often described as mild, moderate, or severe according to International Index of Erectile Function (IIEF5) questionnaire, with a score of 1-7 indicating severe ED, 08-11 moderate ED, 12-16 mild-moderate ED, 17-21 mild ED, and 22-25 no ED.
12 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de agosto de 2026

Finalización primaria (Estimado)

1 de agosto de 2027

Finalización del estudio (Estimado)

1 de agosto de 2027

Fechas de registro del estudio

Enviado por primera vez

21 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

21 de junio de 2026

Publicado por primera vez (Actual)

25 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

5 de agosto de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

2 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 369/IRB

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .